Scancell Holdings Plc

Type: Company
Name: Scancell Holdings Plc
First reported Aug 18 2014 - Updated Aug 18 2014 - 2 reports

Scancell Issues New Date on SCIB1 with Checkpoint Inhibitors

Scancell Holdings said it released new data demonstrating thatanimals treated with a combination of SCIB1, Scancell's ImmunoBodyvaccine in development for the treatment of melanoma, and checkpointinhibition (blockade of the PD-1 immune checkpoint pathway), ... [Published HighBeam Research - Aug 18 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Endometrial Cancer - Pipeline Review, H2 2014 - New Report Available

Boston, MA -- ( ReleaseWire ) -- 08/13/2014 -- Global Markets Direct's, 'Endometrial Cancer - Pipeline Review, H2 2014', provides an overview of the Endometrial Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic ... [Published SBWire - Aug 13 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Data said to support cancer hypothesis

Scancell Holdings Plc said that a study in animals which combined its cancer vaccine SCIB1 with a checkpoint inhibitor showed enhanced tumour destruction and longer survival times, supporting the hypothesis that the best outcomes in humans may be from ... [Published MedNous - Aug 13 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 3 reports

Scancell Holdings Plc: Synergy of SCIB1 With Checkpoint Inhibitors

Combining SCIB1 With PD-1 Blockade Enhances Tumour Destruction and Extends Survival Times ... [Published Marketwire - Breaking News Releases - Aug 12 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

UK WINNERS & LOSERS: Just Eat Delivers Tasty Revenue Growth

LONDON ( Alliance News ) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.-------FTSE 100 - WINNERS-------Prudential, up 2.0%. The financial services group upped its interim dividend by 15% to 11.19 ... [Published HispanicBusiness.com - Aug 12 2014]
First reported Jun 05 2014 - Updated Jun 05 2014 - 1 reports

This week: Clear skies for RapidCloud, Fitbug ups the pace, MediaZest kicks of World Cup

AVCT secures funding award, BGO AGM statement, Blue Inc. intention to float on AIM, BVM contract award, CGNR trenching at Clay Lake, EKF Board appointment and new data, FITB final results, MAGP operations update, MARI first day of dealings, MDZ contract ... [Published Proactiveinvestors United Kingdom RSS feed - Jun 05 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

This week: Flowgroup fully charged, Venture Life’s a peach on AIM

AVCT update on affirmers,BILL final results,BJU full year results,CPP disposal,EHP interim results,FLOW order from Trane,HZM PFS results,MSMN first day of dealings,SCHO intention to float on AIM,SCLP study on track,SMA placing,Tekcapital intention to ... [Published Proactiveinvestors United Kingdom website - Mar 27 2014]

Quotes

...In its release, Scancell noted: "We have previously shown that administration of SCIB1 alone induced potent tumour-specific T cell responses associated with increased T cell infiltration into the tumour and enhanced proliferation of T cells within the tumour resulting in tumour rejection and long-term survival in 50 percent of animals. In our new study, PD-1 blockade, when used alone, resulted in tumour rejection and long-term survival in 55 percent of animals. However, the combination of PD-1 blockade with SCIB1 vaccination further enhanced T cell infiltration, resulting in tumour rejection and long-term survival in 85 percent of animals. These results highlight the potential benefits of combining SCIB1 with PD-1 blockade in the treatment of cancer."
...7 million , from GBP55.1 million the year before, despite revenue rising to GBP577.8 million from GBP563.0 million . "With the new Premiership football season kicking off this weekend, traders are buoyed with confidence that Ladbrokes' new online platform can form the basis for a solid operational performance going forward" said Accendo Markets trader Samuel Springett
...Mark Hardy, Group Managing Director remarked: "We have worked with this customer in the past and we are delighted that it has returned to us and is placing its trust in Belgravium to deliver an integral part of its on-board retail solution. We are working closely with the customer to ensure that the solution is in place and operational as soon as possible so that it can continue to improve the efficiency of its daily operations and deliver an exemplary level of customer service to its patrons."  

More Content

All (15) | News (12) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Scancell Issues New Date on SCIB1 with Checkpoi... [Published HighBeam Research - Aug 18 2014]
Scancell Issues New Date on SCIB1 with Checkpoi... [Published Individual.com - Aug 18 2014]
Endometrial Cancer - Pipeline Review, H2 2014 -... [Published SBWire - Aug 13 2014]
Data said to support cancer hypothesis [Published MedNous - Aug 13 2014]
Scancell Holdings Plc: Synergy of SCIB1 With Ch... [Published Marketwire - Breaking News Releases - Aug 12 2014]
UK WINNERS & LOSERS: Just Eat Delivers Tasty Re... [Published HispanicBusiness.com - Aug 12 2014]
Scancell Holdings PLC announces combining SCIB1... [Published Reuters - Aug 12 2014]
Scancell Hlds : Synergy of SCIB1 with checkpoin... [Published Investegate - Aug 12 2014]
This week: Clear skies for RapidCloud, Fitbug u... [Published Proactiveinvestors United Kingdom RSS feed - Jun 05 2014]
This week: Flowgroup fully charged, Venture Lif... [Published Proactiveinvestors United Kingdom website - Mar 27 2014]
Scancell shares rise to 2month high on FDA orph... [Published BioPortfolio - Feb 11 2014]
Scancell shares rise to 2-month high on FDA orp... [Published Proactiveinvestors United Kingdom website - Feb 11 2014]
Scancell Holdings receives Japanese patent for ... [Published PharmaBiz - Dec 16 2013]
New data for SCIB1 in metastatic melanoma [Published TrustNet - Dec 09 2013]
AIM Notice - 21/11/2013 [Published TrustNet - Nov 21 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Scancell Holdings Plc: Synergy of SCIB1 With Ch... [Published Marketwire - Breaking News Releases - Aug 12 2014]
Combining SCIB1 With PD-1 Blockade Enhances Tumour Destruction and Extends Survival Times ...
This week: Flowgroup fully charged, Venture Lif... [Published Proactiveinvestors United Kingdom website - Mar 27 2014]
AVCT update on affirmers,BILL final results,BJU full year results,CPP disposal,EHP interim results,FLOW order from Trane,HZM PFS results,MSMN first day of dealings,SCHO intention to float on AIM,SCLP study on track,SMA placing,Tekcapital intention to ...
Scancell shares rise to 2-month high on FDA orp... [Published Proactiveinvestors United Kingdom website - Feb 11 2014]
Shares in Scancell Holdings ( LON:SCLP ) rose to a two-month high after US Food and Drug Administration granted orphan drug designation (ODD) to the company’s SCIB1 ImmunoBody for the treatment of later-stage cancer. “We believe that the award of ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.